Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Cytohesin-3 is upregulated in hepatocellular carcinoma and contributes to tumor growth and vascular invasion.

Fu Y, Li J, Feng MX, Yang XM, Wang YH, Zhang YL, Qin W, Xia Q, Zhang ZG.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2123-32. eCollection 2014.

2.

Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.

Zhan DQ, Wei S, Liu C, Liang BY, Ji GB, Chen XP, Xiong M, Huang ZY.

J Gastroenterol Hepatol. 2012 Jan;27(1):173-80. doi: 10.1111/j.1440-1746.2011.06847.x.

PMID:
21777276
3.

Cytohesin-2 as a novel prognostic marker for hepatocellular carcinoma.

Xu K, Gao J, Yang X, Yao Y, Liu Q.

Oncol Rep. 2013 Jun;29(6):2211-8. doi: 10.3892/or.2013.2366. Epub 2013 Mar 26.

PMID:
23545718
4.

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Zhou Y, Zhou N, Fang W, Huo J.

Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58.

5.

Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.

Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z.

World J Gastroenterol. 2015 Apr 7;21(13):3983-93. doi: 10.3748/wjg.v21.i13.3983.

6.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
7.

CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma.

Shi JY, Yang LX, Wang ZC, Wang LY, Zhou J, Wang XY, Shi GM, Ding ZB, Ke AW, Dai Z, Qiu SJ, Tang QQ, Gao Q, Fan J.

J Pathol. 2015 Mar;235(4):546-58. doi: 10.1002/path.4450. Epub 2014 Dec 18.

PMID:
25255875
8.

Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma.

Mayinuer A, Yasen M, Mogushi K, Obulhasim G, Xieraili M, Aihara A, Tanaka S, Mizushima H, Tanaka H, Arii S.

Ann Surg Oncol. 2013 Jan;20(1):305-17. doi: 10.1245/s10434-012-2395-2. Epub 2012 Oct 13.

9.

Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.

Dai B, Ruan B, Wu J, Wang J, Shang R, Sun W, Li X, Dou K, Wang D, Li Y.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):5645-54. eCollection 2014.

10.

Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.

Xu P, Zhang X, Ni W, Fan H, Xu J, Chen Y, Zhu J, Gu X, Yang L, Ni R, Chen B, Shi W.

Dig Dis Sci. 2015 Nov;60(11):3351-63. doi: 10.1007/s10620-015-3774-x. Epub 2015 Jun 30.

PMID:
26123838
11.

Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.

Hsieh SY, He JR, Hsu CY, Chen WJ, Bera R, Lin KY, Shih TC, Yu MC, Lin YJ, Chang CJ, Weng WH, Huang SF.

Hepatology. 2011 Feb;53(2):504-16. doi: 10.1002/hep.24083. Epub 2011 Jan 18.

PMID:
21246584
12.

A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.

Liu F, Zhu C, Huang X, Cai J, Wang H, Wang X, He S, Liu C, Yang X, Zhang Y, Zhang T.

Pathol Res Pract. 2014 Dec;210(12):885-92. doi: 10.1016/j.prp.2014.07.011. Epub 2014 Aug 9.

PMID:
25169131
13.

SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma.

Li C, Yang W, Zhang J, Zheng X, Yao Y, Tu K, Liu Q.

Int J Mol Sci. 2014 Apr 25;15(5):7124-38. doi: 10.3390/ijms15057124.

14.

MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1.

Liu Y, Ding Y, Huang J, Wang S, Ni W, Guan J, Li Q, Zhang Y, Ding Y, Chen B, Chen L.

PLoS One. 2014 Feb 13;9(2):e88393. doi: 10.1371/journal.pone.0088393. eCollection 2014.

15.

Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma.

Li C, Wang J, Zhang H, Zhu M, Chen F, Hu Y, Liu H, Zhu H.

Oncotarget. 2014 Sep 30;5(18):8429-41.

16.

Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.

Gu H, Guo X, Zou L, Zhu H, Zhang J.

Mol Cell Biochem. 2013 Mar;375(1-2):23-30. doi: 10.1007/s11010-012-1521-6. Epub 2013 Jan 6.

PMID:
23291979
17.

Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.

Liu WT, Jing YY, Yu GF, Han ZP, Yu DD, Fan QM, Ye F, Li R, Gao L, Zhao QD, Wu MC, Wei LX.

Cancer Lett. 2015 Mar 28;358(2):136-43. doi: 10.1016/j.canlet.2014.12.019. Epub 2014 Dec 12.

PMID:
25511737
18.

Upregulated expression of CAP1 is associated with tumor migration and metastasis in hepatocellular carcinoma.

Liu Y, Cui X, Hu B, Lu C, Huang X, Cai J, He S, Lv L, Cong X, Liu G, Zhang Y, Ni R.

Pathol Res Pract. 2014 Mar;210(3):169-75. doi: 10.1016/j.prp.2013.11.011. Epub 2013 Dec 5.

PMID:
24359721
19.

Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.

Zha TZ, Hu BS, Yu HF, Tan YF, Zhang Y, Zhang K.

Tumour Biol. 2012 Dec;33(6):2125-34. doi: 10.1007/s13277-012-0472-6. Epub 2012 Aug 4.

PMID:
22864671
20.

Embryonic morphogen nodal is associated with progression and poor prognosis of hepatocellular carcinoma.

Chen J, Liu WB, Jia WD, Xu GL, Ma JL, Ren Y, Chen H, Sun SN, Huang M, Li JS.

PLoS One. 2014 Jan 21;9(1):e85840. doi: 10.1371/journal.pone.0085840. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk